The overall goal of hepatitis C elimination for PWID should be improved quality of life and enhanced access to high-quality, non-judgmental healthcare and prevention services, resulting in reductions in morbidity and mortality broadly. More
The toolkit provides guidance across three core areas with the aim of supporting advocacy efforts for the scale-up or implementation of prison-based hepatitis C testing, treatment and prevention services. More
Harm Reduction International releases the 9th edition of the Global State of Harm Reduction report, providing an independent analysis of harm reduction in the world. More
The purpose of the guide is to support countries in developing policies that define a strategic mix of hepatitis B and C testing approaches, tailored to their unique situation ensuring an impactful national response to the hepatitis epidemic. More
Treatment Action Group releases a trials tracker providing a compilation of ongoing and recently completed clinical trials on long-acting therapies for HCV, malaria, and opioid use and overdose prevention in the R&D pipeline. More
